Skip to content

Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans

Pilot Study of the Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00597350
Acronym
Fenugreek
Enrollment
8
Registered
2008-01-18
Start date
2007-11-30
Completion date
2008-02-29
Last updated
2015-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Fenugreek, Trigonella foenum-graecum, Diabetes mellitus, Blood sugar, Insulin, Glucose

Brief summary

The purpose of this study is to determine if bread containing fenugreek reduces blood sugar and insulin compared to identical bread without fenugreek.

Detailed description

Trigonella foenum-graecum (fenugreek) has been used in traditional medicine for the treatment of diabetes. Fenugreek has been demonstrated to lower blood glucose in response to a glucose load while leaving the levels of serum insulin unaffected in rodents. This effect of lowering blood sugar without changing insulin levels demonstrates improved insulin action. Fenugreek has also been shown to decrease glucose absorption by inhibiting intestinal disaccharidases. Fenugreek decreases glycohemoglobin in diabetic rodents. An amino acid extracted from fenugreek seeds, 4-hydroxyisoleucine, decreases glucose and insulin in diabetic rodents, improves glucose tolerance and stimulates insulin secretion from isolated pancreatic rodent islets. Fenugreek imparts a bitter taste to products into which it is placed, and this property has limited its use in treating diabetes. Dr. Losso and his associates developed a process that allows incorporation of fenugreek into bread and other bakery goods without imparting a bitter taste, and the success of this process was confirmed in taste testing. This study is designed to evaluate the effect of fenugreek bread made by Dr. Losso's proprietary process on glucose and insulin.

Interventions

DIETARY_SUPPLEMENTTrigonella foenum-graecum (fenugreek)

2 slices of bread containing 5 grams of the natural herb fenugreek 2 times, 1 week apart

Sponsors

Louisiana State University Health Sciences Center in New Orleans
CollaboratorOTHER
Pennington Biomedical Research Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female with diet controlled diabetes mellitus. * Between 18 and 70 years of age.

Exclusion criteria

* Pregnant or nursing. * Taking medication for diabetes or a medication like oral cortisone that is known to affect blood sugar or blood insulin. * Taking any chronic medication that has not had a stable dose for 1 month or longer. Oral contraceptives are accepted.

Design outcomes

Primary

MeasureTime frame
Area under the curve for insulin and glucose4 hrs. after eating the bread

Secondary

MeasureTime frame
Any adverse event experienced by the subjects2 times, 1 wk. apart

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026